AT309427B - Verfahren zur Herstellung neuer schwefelhaltiger Pyridinderivate - Google Patents

Verfahren zur Herstellung neuer schwefelhaltiger Pyridinderivate

Info

Publication number
AT309427B
AT309427B AT1133669A AT1133669A AT309427B AT 309427 B AT309427 B AT 309427B AT 1133669 A AT1133669 A AT 1133669A AT 1133669 A AT1133669 A AT 1133669A AT 309427 B AT309427 B AT 309427B
Authority
AT
Austria
Prior art keywords
production
pyridine derivatives
containing pyridine
new sulfur
sulfur
Prior art date
Application number
AT1133669A
Other languages
English (en)
Original Assignee
Merck Ag E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Ag E filed Critical Merck Ag E
Application granted granted Critical
Publication of AT309427B publication Critical patent/AT309427B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT1133669A 1968-12-05 1969-12-04 Verfahren zur Herstellung neuer schwefelhaltiger Pyridinderivate AT309427B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1812794A DE1812794C3 (de) 1968-12-05 1968-12-05 2-Methyl-3-hydroxy-5-methylthiomethylpyridinderivate und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
AT309427B true AT309427B (de) 1973-08-27

Family

ID=5715283

Family Applications (4)

Application Number Title Priority Date Filing Date
AT1133669A AT309427B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung neuer schwefelhaltiger Pyridinderivate
AT732072A AT311347B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung von neuen schwefelhaltigen Pyridinderivaten
AT732172A AT311970B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung von neuen schwefelhaltigen Pyridinderivaten
AT731972A AT309430B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung von neuen schwefelhaltigen Pyridinderivaten

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT732072A AT311347B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung von neuen schwefelhaltigen Pyridinderivaten
AT732172A AT311970B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung von neuen schwefelhaltigen Pyridinderivaten
AT731972A AT309430B (de) 1968-12-05 1969-12-04 Verfahren zur Herstellung von neuen schwefelhaltigen Pyridinderivaten

Country Status (16)

Country Link
US (2) US3658825A (de)
JP (1) JPS5243834B1 (de)
AT (4) AT309427B (de)
BE (1) BE742641A (de)
BR (1) BR6914813D0 (de)
CH (4) CH544756A (de)
CS (3) CS164838B2 (de)
DE (1) DE1812794C3 (de)
DK (1) DK141050B (de)
ES (1) ES374266A1 (de)
FR (1) FR2025454A1 (de)
GB (1) GB1263370A (de)
IL (1) IL33437A (de)
IT (1) IT7947631A0 (de)
NL (1) NL167421C (de)
SE (1) SE366310B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336441A (en) * 1991-05-29 1994-08-09 Petrolite Corporation Corrosion inhibition in highly acidic environments by use of pyridine salts in combination with certain cationic surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220422B (de) * 1963-09-07 1966-07-07 Merck Ag E Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
US3525749A (en) * 1969-03-19 1970-08-25 Merck & Co Inc Certain 1,3-dioxepino-(5,6-c)-pyridines

Also Published As

Publication number Publication date
AT309430B (de) 1973-08-27
CH562797A5 (de) 1975-06-13
CH544756A (de) 1973-11-30
BE742641A (fr) 1970-06-04
AT311347B (de) 1973-11-12
GB1263370A (en) 1972-02-09
DE1812794B2 (de) 1978-02-02
FR2025454A1 (fr) 1970-09-11
BR6914813D0 (pt) 1973-03-08
JPS5243834B1 (de) 1977-11-02
NL6918252A (nl) 1970-06-09
ES374266A1 (es) 1972-03-16
DE1812794A1 (de) 1970-07-02
CS164838B2 (de) 1975-11-28
DE1812794C3 (de) 1978-10-05
IL33437A0 (en) 1970-01-29
CS164836B2 (de) 1975-11-28
US3759930A (en) 1973-09-18
US3658825A (en) 1972-04-25
DK141050C (de) 1980-06-16
IT7947631A0 (it) 1979-01-15
NL167421C (nl) 1981-12-16
CH545291A (de) 1974-01-31
NL167421B (nl) 1981-07-16
AT311970B (de) 1973-12-10
FR2025454B1 (de) 1974-05-24
IL33437A (en) 1973-03-30
SE366310B (sv) 1974-04-22
CS164837B2 (de) 1975-11-28
DK141050B (da) 1979-12-31
CH544757A (de) 1974-01-15

Similar Documents

Publication Publication Date Title
AT326674B (de) Verfahren zur herstellung neuer naphthyridinderivaten
AT294331B (de) Verfahren zur Herstellung neuer Isoxazolderivate
CH508627A (de) Verfahren zur Herstellung neuer Hexahydrobenzazocine
CH513907A (de) Verfahren zur Herstellung neuer Thiazolderivate
AT306256B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
CH505805A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
CH535730A (de) Verfahren zur Herstellung neuer Naphthylalkanole
AT310361B (de) Verfahren zur Herstellung neuer Evomonosid-Derivate
CH518251A (de) Verfahren zur Herstellung neuer Prostaglandinderivate
CH507244A (de) Verfahren zur Herstellung neuer Pyridin-Derivate
CH517728A (de) Verfahren zur Herstellung neuer basisch substituierter Cumarinderivate
CH536843A (de) Verfahren zur Herstellung neuer Hexahydroazepine
AT295512B (de) Verfahren zur Herstellung neuer Pyrrolderivate
AT309427B (de) Verfahren zur Herstellung neuer schwefelhaltiger Pyridinderivate
CH498817A (de) Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine
CH511886A (de) Verfahren zur Herstellung neuer Furanonderivate
AT310962B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate
CH537370A (de) Verfahren zur Herstellung neuer Guanidin-Derivate
CH497402A (de) Verfahren zur Herstellung neuer Isothiocyanato-N-alkanoyl-diphenylamine
AT299941B (de) Verfahren zur Herstellung neuer Thiazolderivate
AT297952B (de) Verfahren zur Herstellung neuer Halogenpregnadiene
CH497401A (de) Verfahren zur Herstellung neuer Isothiocyanato-N-nitroso-diphenylamine
CH520698A (de) Verfahren zur Herstellung neuer Piperazinoindole
CH536297A (de) Verfahren zur Herstellung neuer 18-Methyl-5a-H-androstane
CH513840A (de) Verfahren zur Herstellung neuer Östradiol-Derivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee